| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MORF | Common Stock | Options Exercise | $750,000 | +50,000 | +207% | $15.00 | 74,136 | 25 Apr 2023 | Direct | |
| transaction | MORF | Common Stock | Sale | $2,735,500 | -50,000 | -67% | $54.71 | 24,136 | 25 Apr 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MORF | Stock Option (right to buy Common Stock) | Options Exercise | $0 | -50,000 | -39% | $0.000000 | 77,268 | 25 Apr 2023 | Common Stock | 50,000 | $15.00 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated June 28, 2022. |
| F2 | The option vested as to 25% of the total shares on April 6, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on April 6, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date. |